• 1. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 4. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Aromatic monoterpenoids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Monoterpenoids Aromatic monoterpenoids

Introduction to 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine (CAS No. 3524-29-6)

1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine, identified by its CAS number 3524-29-6, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic amine derivative has garnered attention due to its structural complexity and potential biological activities, making it a subject of extensive study in drug discovery and development.

The molecular structure of 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine consists of a pyrazole core substituted with an amine group at the 5-position and an isopropylphenylmethyl side chain at the 1-position. This unique arrangement imparts distinct chemical and pharmacological properties, which have been explored in various preclinical and clinical studies. The compound's ability to interact with biological targets has positioned it as a promising candidate for therapeutic applications.

In recent years, there has been a surge in research focusing on pyrazole derivatives due to their versatility and efficacy in modulating biological pathways. Pyrazoles are known for their role as scaffolds in drug design, offering a balance between structural flexibility and biological activity. The presence of the isopropylphenylmethyl group in 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine enhances its binding affinity to certain enzymes and receptors, making it a valuable tool in pharmacological investigations.

One of the most compelling aspects of this compound is its potential application in the treatment of neurological disorders. Studies have demonstrated that pyrazole derivatives can interact with neurotransmitter systems, potentially offering therapeutic benefits in conditions such as depression, anxiety, and neurodegenerative diseases. The amine functionality at the 5-position of the pyrazole ring allows for further derivatization, enabling the synthesis of analogs with enhanced pharmacological profiles.

Furthermore, the isopropylphenylmethyl moiety has been shown to influence the metabolic stability and bioavailability of pharmaceutical compounds. This feature makes 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine an attractive candidate for drug development, as it can be optimized to meet specific pharmacokinetic requirements. Researchers have leveraged this compound in studies aimed at identifying novel inhibitors of enzymes involved in metabolic pathways, highlighting its importance in drug discovery.

The synthesis of 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine involves multi-step organic reactions that require precise control over reaction conditions. The introduction of the pyrazole ring is typically achieved through condensation reactions, while the attachment of the isopropylphenylmethyl group often involves Grignard reactions or other coupling techniques. These synthetic methodologies ensure high yields and purity, which are crucial for downstream applications.

Recent advancements in computational chemistry have further enhanced the study of 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine. Molecular modeling techniques allow researchers to predict binding interactions between this compound and biological targets with remarkable accuracy. This approach has accelerated the drug discovery process by enabling virtual screening of potential candidates before experimental validation.

The pharmacological evaluation of 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine has revealed several promising activities. In vitro studies have shown that it can modulate enzymes such as cytochrome P450 isoforms, which play a critical role in drug metabolism. Additionally, its interaction with receptors like serotonin and dopamine receptors suggests potential applications in central nervous system disorders.

Preclinical studies have also explored the toxicological profile of this compound, providing insights into its safety margins and potential side effects. These investigations are essential for advancing into clinical trials, where further evaluation of its therapeutic efficacy will be conducted. The results from these studies will determine whether 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine can progress to human testing for various medical conditions.

The versatility of 1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine extends beyond its direct therapeutic applications. It serves as a valuable intermediate in the synthesis of more complex molecules, allowing chemists to explore novel chemical space for drug development. This adaptability underscores its importance as a building block in medicinal chemistry.

In conclusion, 1-{4-(propan-2-yi)phenylethymethy}l - 11 H - pyra z ol - 5 - am ine (CAS No . 3524 - 29 - 6) is a multifaceted compound with significant potential in pharmaceutical research . Its unique structure , coupled with its demonstrated biological activities , makes it a compelling subject for further investigation . As research continues to uncover new therapeutic applications , this compound is poised to play a crucial role in the development of next-generation pharmaceuticals . p >

• 3524-13-8(1-(1-Phenylethyl)-1H-pyrazol-5-amine)
• 3528-51-6(2-benzylpyrazol-3-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)